Isoprenaline-induced damage in cardiac and skeletal muscle: Interaction with methylxanthines

Drug Development Research

Volumn 37, Issue 4, 1996, Pages 249-258

  Heap, Sarah J ^a   Hudlicka, Olga ^a   Okyayuz Baklouti, Ismahan ^b  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b SANOFI   (France)

Author keywords

Caffeine; Necrosis; Performance; Torbafylline

Indexed keywords

CAFFEINE; ISOPRENALINE; TORBAFYLLINE;

ANIMAL EXPERIMENT; ARTICLE; CARDIOTOXICITY; CHRONOTROPISM; DOSE RESPONSE; DRUG EFFECT; HEART MUSCLE NECROSIS; INOTROPISM; MALE; MUSCLE NECROSIS; NONHUMAN; RAT; SOLEUS MUSCLE;

EID: 0030036557     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199604)37:4<249::AID-DDR6>3.0.CO;2-L     Document Type: Article

References (59)

1. Aboudrar S, Desplanches D, Graber-von-Bergen F, Favier R, Okyayuz-Baklouti I, Hoppeler H. (1992): Effects of torbafylline on muscle atrophy: prevention and recovery. Can J Physiol Pharmacol 70:814-820.
2. Berglund B, Hemmingson P (1982): Effects of caffeine ingestion on exercise performance at low and high altitude in cross-country skiers. Int J Sports Med 3:234-236.
3. Bowman WC, Zaimis E (1958): The effects of adrenaline, noradrenaline and isoprenaline on skeletal muscle contractions in the cat. J Physiol (Lond) 144:92-107.
4. Brown MD, Hudlicka O (1988): Protective effects of long-term bradycardial pacing against catecholamine-induced myocardial damage in rabbit hearts. Circ Res 62:965-974.
5. Brown MD, Hudlicka O (1991): Capillary supply and cardiac performance in the rabbit after chronic dobutamine treatment. Cardiovasc Res 25:909-915.
6. Brust M (1976): Fatigue and caffeine effects in fast-twitch and slow-twitch muscles of the mouse. Pfugers Arch 367:189-200.
7. Cairns SP, Dulhunty AF (1993): The effects of beta-adrenoceptor activation on contraction in isolated fast-twitch and slow-twitch skeletal muscle fibres of the rat. Br J Pharmacol 110:1133-1141.
8. Christensen NJ, Videback J (1974): Plasma catecholamines and carbohydrate metabolism in patients with acute myocardial infarction. J Clin Invest 54:278-286.
9. 2 supply/consumption in hypertension-induced myocardial hypertrophy. Am J Physiol 259:H346-H351.
10. Close RI (1964): Dynamic properties of fast and slow skeletal muscles of the rat during development. J Physiol (Lond) 173:74-95.
11. Close RI (1965): The relationship between the intrinsic speed of shortening and duration of the active state of the muscle. J Physiol (Lond) 180:542-559.
12. Collomp K, Ahmaidi S, Chatard JC, Audran M, Prefaut C (1992): Benefits of caffeine ingestion on sprint performance in trained and untrained swimmers. Eur J Appl Physiol Occup Physiol 64:4.
13. Corsi A, Granata AL, Hudlicka O (1990): Effect of activity on performance and morphology in ischaemic rat slow muscles. J Exp Biol 152:265-279.
14. Costill DL, Dalsky GP, Fink WJ (1978): Effects of caffeine ingestion on metabolism and exercise performance. Med Sci Sports 10:155-158.
15. Dawson JM, Hudlicka O (1990): Changes in the microcirculation in slow and fast skeletal muscles with long-term limitations of blood supply. Cardiovasc Res 24:390-395.
16. Dawson JM, Okyayuz-Baklouti I, Hudlicka O (1990): Skeletal muscle microcirculation: The effects of limited blood supply and treatment with torbafylline. Int J Microcirc Clin Exp 9:385-400.
17. Derom E, Janssens S, Gurrieri G, Tjandramaga T, Decramer M (1992): Effects of broxaterol and theophylline on fatigued canine diaphragm in vivo - a randomised controlled study. Am Rev Respir Dis 146:22-25.
18. Egginton S, Hudlicka O (1992): Regional capillary perfusion in muscles with limited blood supply: effects of torbafylline. Pflugers Arch 421:336-342.
19. Endo M, Kitazawa T, Yagi S (1980): Different features of responses of the sarcoplasmic reticulum in cardiac and smooth muscle. In Ebashi S, et al (eds): Muscle Contraction - Its Regulating Mechanisms. Japan Science Society Press/Springer-Verlag, pp 447-463.
20. Fleckenstein A (1971): Specific inhibitors and promotors of calcium action in the excitation-contraction coupling of heart muscle and their role in the prevention and production of myocardial lesions. In Harris P, and and L. Opie (eds): Calcium and the Heart. London: Academic Press, pp 135-188.
21. Fleckenstein A (1983): Calcium Antagonism in Heart and Smooth Muscle - experimental facts and therapeutic prospects. John Wiley & Sons, New York, pp 109-120.
22. Fryer MW, Neering IR (1989): Actions of caffeine on fast- and slow-twitch muscles of the rat. J Physiol (Lond) 416:435-454.
23. Holycross BJ, Jackson EK (1992): Effects of chronic treatment with caffeine on kidney responses to angiotensin II. Eur J Pharmacol 219:361-367.
24. Hudlicka O, Egginton S, Brown MD, Okyayuz-Baklouti I (1994): Effect of torbafylline on muscle blood flow, performance, and capillary supply in ischemic muscles subjected to varying levels of activity. Can J Physiol Pharmacol 72:811-817.
25. Kondo T, Ogawa Y, Sugiyama S, Ito T, Satake T, Ozawa T (1987) Mechanism of isoproterenol-induced myocardial damage. Cardiovasc Res 21:248-254.
26. Lubbe WF, Podzuweit T, Opie LH (1992): Potential arrhythmogenic role of cyclic adenosine monophosphate (AMP) and cytosolic calcium overload: Implications for prophylactic effects of beta-blockers in myocardial infarction and proarrhythmic effects of phosphodiesterase inhibitors. J Am Coll Cardiol 19: 1622-1633.
27. Marcus ML, Skelton CL, Grauer LE, Epstein SE (1972): Effects of theophylline on myocardial mechanics. Am J Physiol 222:1361-1365.
28. Martin WH, Murphree SS, Saffitz JE (1989): β-Adrenergic receptor distribution among muscle fibre types and resistance arterioles of white, red and intermediate skeletal muscles. Circ Res 64:1096-1105.
29. Meliska CJ, Landrum RE, Landrum TA (1990): Tolerance and sensitisation to chronic oral caffeine: Effects on wheel-running in rats. Pharmacol Biochem Behav 35:477-479.
30. Mukherjee C, Caron MG, Lefkowitz RJ (1976): Regulation of adenylate cyclase coupled by b-adrenergic catecholamines. Endocrinology 99:347-357.
31. Nicklas RA, Balazs T (1986): Adverse effects of theophylline-beta agonist interactions. J Allergy Clin Immunol 78:806-811.
32. Nolte J, Brdiczka D, Pette D (1972): Intracellular distribution of phosphoenol pyruvate carboxylase and (NADP) malate dehydrogenase in different muscle types. Biochim. Biophys Acta 284: 497-507.
33. 2 and function of rat ischaemic skeletal muscle. Eur J Pharmacol 166:75-86.
34. Paul O, Leper MH, Phelan WH, Dupertuis GW, MacMillan A, McKean H, Peak H (1963): A longitudinal study of coronary heart disease. Circulation 28:20-31.
35. Persson CGA (1986): Overview of effects of theophylline. J Allergy Clin Immunol 78:780-787.
36. Pette D, Staron RS (1990): Cellular and molecular diversities of mammalian skeletal muscle fibers. Rev Physiol Biochem Pharmacol 116:1-76.
37. Raab W (1960): Key position of catecholamine in functional and degenerative cardiovascular pathology. Am J Cardiol 5:571-578.
38. Rona G, Chappel CI, Balazs T, Gaundry R (1959): An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. Arch Pathol 67:443-455.
39. Rona G, Kahn DS, Chappel CI (1961): Study on the healing of cardiac necrosis in the rat. Am J Pathol 39:473-489.
40. Ruffolo RR, Messick K (1985): Systemic haemodynamic effects of dopamine, (+/-)-dobutamine and the (+)- and (-)-enantiomers of dobutamine in anaesthetised normotensive rats. Eur J Pharmacol 109:173-181.
41. Rutherford JD, Vatner ST, Braunwald E (1981): Effects and mechanisms of action of aminophylline on cardiac function and regional blood flow distribution in conscious dogs. Circulation 63:378-387.
42. Sillau AH, Philippi M de L (1987): Long-term isoprenaline administration produces an increase in capillarity in the soleus muscle of the rat. Can J Physiol Pharmacol 65:303-306.
43. 2-adrenoceptor density in female rats. Nauyn-Schmiedebergs Arch Pharmacol 344:449-453.
44. Storstein L (1988): Non-receptor-mediated inotropic drugs. Eur Heart J 9(suppl H):91-93.
45. Sullivan A, Zaimis E (1973): The effect of isoprenaline on cyclic AMP concentrations in skeletal muscle. J Physiol (Lond) 231: 102-103P.
46. Tamm C, Papageorgiou I, Cantalupi I, Lerch R (1992): Caffeine induces a dissociation between contractile function and oxidative metabolism in rat hearts. J Mol Cell Cardiol 92(suppl V): S87.
47. Tashiro N (1973): Effects of isoprenaline on contractions of directly stimulated fast and slow skeletal muscles of the guinea pig. Br J Pharmacol 48:121-131.
48. Taylor PB, Tang Q (1984): Development of isoproterenol-induced cardiac hypertrophy. Can J Physiol Pharmacol 62:384-389.
49. Vatner SF, McRitchie RJ, Braunwald E (1974): Effects of dobutamine on left ventricular performance, coronary dynamics and distribution of cardiac output in conscious dogs. J Clin Invest 53:1265.
50. Veprek P, Batra S, Korecky B, Rakusan K (1991): Isoproterenol-induced rat endomyocardial damage in relationship to local capillary geometry. Basic Res Cardiol 86:434-440.
51. Vetterlein F, Schmidt G (1980a): Effects of isoprenaline on functional capillary density in the subendocardial and subepicardial layer of the rat myocardium. Basic Res Cardiol 75:526-536.
52. Vetterlein F, Schmidt G (1980b): Functional capillary density in skeletal muscle during vasodilatation induced by isoprenaline and muscular exercise. Microvasc Res 20:156-169.
53. Vick J, Joseph X, Whitehurst V, Herman E, Balazs T (1989): Cardiotoxic effects of the combined use of caffeine and isoproterenol in the minipig. J Toxicol Environ Health 26:425-435.
54. Vleeming W, Von Rooij HH, Wemer J, Porsius AJ (1991): Cardiovascular responses to the stereoisomers of dobutamine in isolated rat hearts 48 hours after acute myocardial infarction. J Cardiovasc Pharmacol 17:634-640.
55. Wagner JC (1991): Enhancement of athletic performance with drugs. An overview. Sports Med 12:250-265.
56. Weibel E (1979): Stereological methods. Practical Methods for Biological Morphometry. Vol. 1. London: Academic Press, pp 130-134.
57. Whitehurst VE, Joseph X, Alleva FR, Vick JA, Whittaker P, Zhang J, Fry BE Jr, Balasz T (1994): Enhancement of acute myocardial lesions by asthma drugs in rats. Toxicol Pathol 22: 72-76.
58. Zavecz JH, Anderson WMcD (1992): Role of extracellular calcium in diphragmatic contraction: Effects of ouabain, monensin and ryanodine. J Appl Physiol 73:30-35.
59. 2-receptor agonist. Am J Physiol 254:E726-E732.